Cloudmd Software Services Stock Net Income
CloudMD Software Services fundamentals help investors to digest information that contributes to CloudMD Software's financial success or failures. It also enables traders to predict the movement of CloudMD Pink Sheet. The fundamental analysis module provides a way to measure CloudMD Software's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CloudMD Software pink sheet.
CloudMD |
CloudMD Software Services Company Net Income Analysis
CloudMD Software's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current CloudMD Software Net Income | (30.73 M) |
Most of CloudMD Software's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CloudMD Software Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, CloudMD Software Services reported net income of (30.73 Million). This is 109.0% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The net income for all United States stocks is 105.38% higher than that of the company.
CloudMD Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CloudMD Software's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CloudMD Software could also be used in its relative valuation, which is a method of valuing CloudMD Software by comparing valuation metrics of similar companies.CloudMD Software is currently under evaluation in net income category among its peers.
CloudMD Fundamentals
| Return On Equity | -0.88 | |||
| Return On Asset | -0.0595 | |||
| Profit Margin | (1.06) % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | 45.4 M | |||
| Shares Outstanding | 293.29 M | |||
| Shares Owned By Insiders | 1.26 % | |||
| Shares Owned By Institutions | 0.72 % | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.29 X | |||
| Revenue | 102.33 M | |||
| Gross Profit | 5.76 M | |||
| EBITDA | (20.91 M) | |||
| Net Income | (30.73 M) | |||
| Cash And Equivalents | 29.7 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 22.13 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 1.67 X | |||
| Book Value Per Share | 0.43 X | |||
| Cash Flow From Operations | (21.86 M) | |||
| Earnings Per Share | (0.10) X | |||
| Number Of Employees | 11 | |||
| Beta | 1.59 | |||
| Market Capitalization | 45.15 M | |||
| Total Asset | 327.36 M | |||
| Z Score | 1.2 | |||
| Net Asset | 327.36 M |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in CloudMD Pink Sheet
If you are still planning to invest in CloudMD Software Services check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CloudMD Software's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |